Excessive JAK/STAT3 signaling promotes cancer cell proliferation, survival, angiogenesis, tumor metabolism, and antitumor immunity suppression (Buchert et al., 2016; Zhang et al., 2018). The gene discussed is STAT3; the disease is cancer.